HistoSonics Acquired in $2.25B Deal Led by K5 Global
Deal News | Aug 07, 2025 | Orrick, Herrington & Sutcliffe

HistoSonics, the company behind the Edison Histotripsy System, has announced a significant transaction which sees a majority stake in the company acquired by K5 Global. The deal also involves other prominent investors, including Bezos Expeditions and Wellington Management, valuing HistoSonics at around $2.25 billion. This acquisition is expected to expedite the global expansion of HistoSonics' innovative tumor therapy platform and represents a strategic move by K5 Global in the healthcare and biotechnology sectors. Orrick, Herrington & Sutcliffe played a pivotal advisory role, led by partners Max Cantor, Spencer Cohen, and Matthew Gemello. The transaction aligns with Orrick's strong presence in the global M&A market, where they have ranked among the top five firms globally.
Sectors
- Healthcare
- Biotechnology
- Private Equity
- Legal Advisory
Geography
- United States – The primary companies and advisors involved, such as K5 Global and Orrick, are based in the United States.
Industry
- Healthcare – HistoSonics' operations focus on non-invasive tumor therapy, which falls under the healthcare sector.
- Biotechnology – HistoSonics develops the Edison Histotripsy System, a novel therapy platform, which is a part of the biotechnology industry.
- Private Equity – K5 Global's acquisition of HistoSonics reflects activities in the private equity sector.
- Legal Advisory – Orrick, Herrington & Sutcliffe provided legal advisory services for the M&A transaction.
Financials
- $2.25 Billion – The acquisition deal values HistoSonics at approximately $2.25 billion.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| HistoSonics | Target | Company | A company developing the Edison Histotripsy System, focusing on non-invasive tumor therapies. |
| K5 Global | Bidding Company | Company | A private equity firm leading the acquisition of a majority stake in HistoSonics. |
| Bezos Expeditions | Investor | Company | Part of the syndicate of global investors acquiring HistoSonics. |
| Wellington Management | Investor | Company | A global investment management firm participating in the acquisition of HistoSonics. |
| Orrick, Herrington & Sutcliffe | Legal Advisor | Company | A law firm providing legal advisory services for the acquisition deal. |